Complex Arrhythmia Syndrome in a Knock-In Mouse Model Carrier of the N98S Calm1 Mutation

Wen-Chin Tsai,Shuai Guo,Michael A. Olaopa,Loren J. Field,Jin Yang,Changyu Shen,Ching-Pin Chang,Peng-Sheng Chen,Michael Rubart
DOI: https://doi.org/10.1161/circulationaha.120.046450
IF: 37.8
2020-10-29
Circulation
Abstract:Background: Calmodulin mutations are associated with arrhythmia syndromes in humans. Exome sequencing previously identified a de novo mutation in CALM1 resulting in a p.N98S substitution in a patient with sinus bradycardia and stress-induced bidirectional ventricular ectopy. The objectives of the present study were to determine if mice carrying the N98S mutation knocked into Calm1 replicate the human arrhythmia phenotype and to examine arrhythmia mechanisms. Methods: Mouse lines heterozygous for the Calm1 N98S allele (Calm1 N98S/+ ) were generated using CRISPR/Cas9 technology. Adult mutant mice and their wildtype littermates (Calm1 +/+ ) underwent electrocardiographic monitoring. Ventricular de- and repolarization was assessed in isolated hearts using optical voltage mapping. Action potentials and whole-cell currents as well as [Ca 2+ ] i were measured in single ventricular myocytes using the patch-clamp technique and fluorescence microscopy, respectively. The microelectrode technique was employed for in situ membrane voltage monitoring of ventricular conduction fibers. Results: Two biologically independent knock-in mouse lines heterozygous for the Calm1 N98S allele were generated. Calm1 N98S/+ mice of either sex and line exhibited sinus bradycardia, QT c interval prolongation and catecholaminergic bidirectional ventricular tachycardia. Male mutant mice also showed QRS widening. Pharmacological blockade and activation of β-adrenergic receptors rescued and exacerbated, respectively, the long QT phenotype of Calm1 N98S/+ mice. Optical and electrical assessment of membrane potential in isolated hearts and single left ventricular myocytes, respectively, revealed β-adrenergically induced delay of repolarization. β-adrenergic stimulation increased peak density, slowed inactivation and left-shifted the activation curve of I Ca.L significantly more in Calm1 N98S/+ vs Calm1 +/+ ventricular myocytes, increasing late I Ca.L in the former. Rapidly paced Calm1 N98S/+ ventricular myocytes showed increased propensity to delayed afterdepolarization-induced triggered activity, whereas in situ His-Purkinje fibers exhibited increased susceptibility for pause-dependent early afterdepolarizations. Epicardial mapping of Calm1 N98S/+ hearts showed that both reentry and focal mechanisms contribute to arrhythmogenesis. Conclusions: Heterozygosity for the Calm1 N98S mutation is causative of an arrhythmia syndrome characterized by sinus bradycardia, QRS widening, adrenergically mediated QT c interval prolongation and bidirectional ventricular tachycardia. β-adrenergically induced I Ca.L dysregulation contributes to the long QT phenotype. Pause-dependent early afterdepolarizations and tachycardia-induced delayed afterdepolarizations originating in the His-Purkinje network and ventricular myocytes, respectively, constitute potential sources of arrhythmia in Calm1 N98S/+ hearts.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to determine whether the Calmodulin (CaM) gene carrying the N98S mutation will cause arrhythmia phenotypes in mice similar to those in humans, and to explore its underlying mechanisms. Specifically, the researchers hope to verify the following points: 1. **Establish a knock - in mouse model carrying the N98S mutation**: Generate a mouse model of the Calmodulin gene carrying the N98S mutation through CRISPR/Cas9 technology to simulate the mutation situation in human patients. 2. **Verify whether the mutation directly causes arrhythmia**: Through electrophysiological detection and behavioral experiments, evaluate whether these mutant mice show symptoms similar to those of human patients, such as sinus bradycardia, QT interval prolongation, and catecholamine - induced bidirectional ventricular tachycardia (BVT). 3. **Explore the mechanism by which the mutation causes arrhythmia**: Through a variety of experimental methods (such as optical voltage mapping, patch - clamp technique, and fluorescence microscopy) to study the impact of the mutation on cardiac electrophysiological characteristics, especially the change of L - type calcium channel current (ICa.L) after β - adrenergic receptor activation and its impact on action potential repolarization. ### Main findings - **Electrophysiological characteristics**: Mice carrying the N98S mutation show sinus bradycardia, QT interval prolongation, and QRS complex widening. - **Arrhythmia susceptibility**: After being given catecholamines and caffeine, mutant mice are prone to develop bidirectional ventricular tachycardia (BVT), while wild - type mice do not. - **Role of β - adrenergic receptor**: Activation of the β - adrenergic receptor significantly prolongs the QT interval in mutant mice, which is related to the abnormality of L - type calcium channel current (ICa.L). - **Cell - level mechanism**: Single ventricular myocytes in mutant mice show delayed repolarization and triggered activity after β - adrenergic receptor activation, which may be one of the sources of arrhythmia. - **Local and reentry mechanisms**: Through optical voltage mapping, it is found that arrhythmia in mutant mice may be mediated by a reentry mechanism triggered by local discharge. ### Clinical significance - **Treatment target**: The research results suggest that L - type calcium channel current may be a potential treatment target in long - QT syndrome caused by CaM mutation. - **Anti - bradycardia pacing**: Anti - bradycardia pacing may help to inhibit arrhythmia triggered by after - depolarization. In conclusion, this study not only verifies the pathogenicity of the N98S mutation in mice, but also deeply explores the underlying molecular and cellular mechanisms, providing new insights for the diagnosis and treatment of related diseases.